Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
5 COVID-19 Security Threats to Know About
Some studies
Mitchell
News Release
The COVID-19 Ripple Effect
Mitchell
News Release
COVID-19 Affects Treatment in Kentucky and Texas
Kentucky On June 24, 2020, Commissioner Robert Swisher of the Kentucky Department of Workers' Claims issued an administrative order delay
Mitchell
News Release
California DWC Publishes Draft Pharmacy Fee Schedule Rule
The California Division of Workers' Compensation (DWC) recently published a long-awaited draft pharmaceutical fee schedule rule.
Auto Casualty
Virtual Event
The Changing Insurance Workforce: Trends and Tips for Adapting [Podcast]
On-Demand
We sat down with Mitchell Vice President of Product Management, Rebecca Morgan, to learn more about the changing insurance workforce and what claim
Workers' Comp
Blog
Specialty Drugs' Impact on Overall Costs in 2019
First Script overall prescription trends saw a slight upward shift in 2019.